Alterations in the nuclear proteome of HIV-1 infected T-cells

Virology

Volumn 468, Issue , 2014, Pages 409-420

  DeBoer, Jason ^a   Jagadish, Teena ^b   Haverland, Nicole A ^b   Madson, Christian J ^a   Ciborowski, Pawel ^b,c   Belshan, Michael ^a,c  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c UNIVERSITY OF NEBRASKA LINCOLN   (United States)

Author keywords

HIV 1; Label free MS MS; Nuclear isolation; Proteomics; Virus host interactions

Indexed keywords

ACTIN; CYCLOPHILIN A; CYCLOPHILIN B; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEAT SHOCK PROTEIN 90; INITIATION FACTOR 1 ALPHA 1; MESSENGER RNA BINDING PROTEIN 1; NUCLEAR PROTEIN; NUCLEOLIN; NUCLEOPHOSMIN; POLYADENYLIC ACID BINDING PROTEIN; PROTEIN DEK; PROTEIN HMGB2; PROTEIN SF3A1; PROTEIN SF3B2; PROTEIN SRSF1; PROTEIN TMP0; PROTEIN TOP2A; SERPINE PEPTIDASE INHIBITOR MEMBER 1; UNCLASSIFIED DRUG; VIRUS PROTEIN; VPR PROTEIN; PROTEOME; TRANSCRIPTOME;

ARTICLE; CELL DIVISION; CELL NUCLEUS; CELL TYPE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOWN REGULATION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; NONHUMAN; PHENOTYPE; PROTEIN ANALYSIS; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEOMICS; T LYMPHOCYTE; UPREGULATION; VIRUS REPLICATION; CELL LINE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

CELL LINE; GENE EXPRESSION REGULATION; HIV-1; HUMANS; NUCLEAR PROTEINS; PROTEOME; T-LYMPHOCYTES; TRANSCRIPTOME;

EID: 84907450611     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2014.08.029     Document Type: Article

References (75)

1. Allouch A., Cereseto A. Identification of cellular factors binding to acetylated HIV-1 integrase. Amino Acids 2011, 41(5):1137-1145.
2. Arber S., Krause K.H., Caroni P. s-cyclophilin is retained intracellularly via a unique COOH-terminal sequence and colocalizes with the calcium storage protein calreticulin. J. Cell Biol. 1992, 116(1):113-125.
3. Binder B.R., Christ G., Gruber F., Grubic N., Hufnagl P., Krebs M., Mihaly J., Prager G.W. Plasminogen activator inhibitor 1: physiological and pathophysiological roles. News Physiol. Sci. 2002, 17:56-61.
4. Birse K.M., Burgener A., Westmacott G.R., McCorrister S., Novak R.M., Ball T.B. Unbiased proteomics analysis demonstrates significant variability in mucosal immune factor expression depending on the site and method of collection. PLoS One 2013, 8(11):e79505.
5. Braaten D., Ansari H., Luban J. The hydrophobic pocket of cyclophilin is the binding site for the human immunodeficiency virus type 1 Gag polyprotein. J. Virol. 1997, 71(3):2107-2113.
6. Brass A.L., Dykxhoorn D.M., Benita Y., Yan N., Engelman A., Xavier R.J., Lieberman J., Elledge S.J. Identification of host proteins required for HIV infection through a functional genomic screen. Science 2008, 319(5865):921-926.
7. Bregnard C., Zamborlini A., Leduc M., Chafey P., Camoin L., Saib A., Benichou S., Danos O., Basmaciogullari S. Comparative proteomic analysis of HIV-1 particles reveals a role for Ezrin and EHD4 in the Nef-dependent increase of virus infectivity. J. Virol. 2013, 87(7):3729-3740.
8. Bridges S.M., Magee G.B., Wang N., Williams W.P., Burgess S.C., Nanduri B. ProtQuant: a tool for the label-free quantification of MudPIT proteomics data. BMC Bioinform. 2007, 8(Suppl. 7):S24.
9. Bushman F.D., Malani N., Fernandes J., D'Orso I., Cagney G., Diamond T.L., Zhou H., Hazuda D.J., Espeseth A.S., König R., Bandyopadhyay S., Ideker T., Goff S.P., Krogan N.J., Frankel A.D., Young J.A.T., Chanda S.K. Host Cell Factors in HIV Replication: meta-Analysis of Genome-Wide Studies. PLoS Pathog. 2009, 5(5):e1000437.
10. Chen K.C., Wang T.Y., Chan C.H. Associations between HIV and human pathways revealed by protein-protein interactions and correlated gene expression profiles. PLoS One 2012, 7(3):e34240.
11. Chertova E., Chertov O., Coren L.V., Roser J.D., Trubey C.M., Bess J.W., Sowder R.C., Barsov E., Hood B.L., Fisher R.J., Nagashima K., Conrads T.P., Veenstra T.D., Lifson J.D., Ott D.E. Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages. J. Virol. 2006, 80(18):9039-9052.
12. Cimarelli A., Luban J. Translation elongation factor 1-alpha interacts specifically with the human immunodeficiency virus type 1 Gag polyprotein. J. Virol. 1999, 73(7):5388-5401.
13. Coates P.J., Nenutil R., McGregor A., Picksley S.M., Crouch D.H., Hall P.A., Wright E.G. Mammalian prohibitin proteins respond to mitochondrial stress and decrease during cellular senescence. Exp. Cell Res. 2001, 265(2):262-273.
14. Coiras M., Camafeita E., Ureña T., López J.A., Caballero F., Fernández B., López-Huertas M.R., Pérez-Olmeda M., Alcamí J. Modifications in the human Tcell proteome induced by intracellular HIV-1 Tat protein expression. Proteomics 2006, 6(Suppl. 1):S63-S73.
15. Emerson V., Holtkotte D., Pfeiffer T., Wang I.-H., Schnölzer M., Kempf T., Bosch V. Identification of the cellular prohibitin 1/prohibitin 2 heterodimer as an interaction partner of the C-terminal cytoplasmic domain of the HIV-1 glycoprotein. J. Virol. 2010, 84(3):1355-1365.
16. Engeland C.E., Brown N.P., Börner K., Schümann M., Krause E., Kaderali L., Müller G.A., Kräusslich H.-G. Proteome analysis of the HIV-1 Gag interactome. Virology 2014, 460-461:194-206.
17. Fellay J., Shianna K.V., Ge D., Colombo S., Ledergerber B., Weale M., Zhang K., Gumbs C., Castagna A., Cossarizza A., Cozzi-Lepri A., De Luca A., Easterbrook P., Francioli P., Mallal S., Martinez-Picado J., Miro J.M., Obel N., Smith J.P., Wyniger J., Descombes P., Antonarakis S.E., Letvin N.L., McMichael A.J., Haynes B.F., Telenti A., Goldstein D.B. A whole-genome association study of major determinants for host control of HIV-1. Science 2007, 317(5840):944-947.
18. Franceschini A., Szklarczyk D., Frankild S., Kuhn M., Simonovic M., Roth A., Lin J., Minguez P., Bork P., von Mering C., Jensen L.J. STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res. 2013, 41:D808-D815. (Database issue).
19. Fu W., Sanders-Beer B.E., Katz K.S., Maglott D.R., Pruitt K.D., Ptak R.G. Human immunodeficiency virus type 1, human protein interaction database at NCBI. Nucleic Acids Res. 2009, 37:D417-D422. (Database issue).
20. Fuchigami T., Misumi S., Takamune N., Takahashi I., Takama M., Shoji S. Acid-labile formylation of amino terminal proline of human immunodeficiency virus type 1 p24(gag) was found by proteomics using two-dimensional gel electrophoresis and matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry. Biochem. Biophys. Res. Commun. 2002, 293(3):1107-1113.
21. Ghisolfi-Nieto L., Joseph G., Puvion-Dutilleul F., Amalric F., Bouvet P. Nucleolin is a sequence-specific RNA-binding protein: characterization of targets on pre-ribosomal RNA. J. Mol. Biol. 1996, 260(1):34-53.
22. Giri M.S., Nebozhyn M., Showe L., Montaner L.J. Microarray data on gene modulation by HIV-1 in immune cells: 2000-2006. J. Leukoc. Biol. 2006, 80(5):1031-1043.
23. Haverland N.A., Fox H.S., Ciborowski P. Quantitative proteomics by SWATH-MS reveals altered expression of nucleic acid binding and regulatory proteins in HIV-1-infected macrophages. J. Proteome Res. 2014, 13(4):2109-2119.
24. He F., Zeng Y., Wu X., Ji Y., He X., Andrus T., Zhu T., Wang T. Endogenous HIV-1 Vpr-mediated apoptosis and proteome alteration of human T-cell leukemia virus-1 transformed C8166 cells. Apoptosis 2009, 14(10):1212-1226.
25. He G., Andersen O., Haugaard S.B., Lihn A.S., Pedersen S.B., Madsbad S., Richelsen B. Plasminogen activator inhibitor type 1 (PAI-1) in plasma and adipose tissue in HIV-associated lipodystrophy syndrome. Implications of adipokines. Eur. J. Clin. Invest. 2005, 35(9):583-590.
26. Heaton J.H., Dlakic W.M., Dlakic M., Gelehrter T.D. Identification and cDNA cloning of a novel RNA-binding protein that interacts with the cyclic nucleotide-responsive sequence in the Type-1 plasminogen activator inhibitor mRNA. J. Biol. Chem. 2001, 276(5):3341-3347.
27. Inder K.L., Lau C., Loo D., Chaudhary N., Goodall A., Martin S., Jones A., van der Hoeven D., Parton R.G., Hill M.M., Hancock J.F. Nucleophosmin and nucleolin regulate K-Ras plasma membrane interactions and MAPK signal transduction. J. Biol. Chem. 2009, 284(41):28410-28419.
28. Jager S., Cimermancic P., Gulbahce N., Johnson J.R., McGovern K.E., Clarke S.C., Shales M., Mercenne G., Pache L., Li K., Hernandez H., Jang G.M., Roth S.L., Akiva E., Marlett J., Stephens M., D'Orso I., Fernandes J., Fahey M., Mahon C., O'Donoghue A.J., Todorovic A., Morris J.H., Maltby D.A., Alber T., Cagney G., Bushman F.D., Young J.A., Chanda S.K., Sundquist W.I., Kortemme T., Hernandez R.D., Craik C.S., Burlingame A., Sali A., Frankel A.D., Krogan N.J. Global landscape of HIV-human protein complexes. Nature 2011, 481(7381):365-370.
29. Jarboui M.A., Bidoia C., Woods E., Roe B., Wynne K., Elia G., Hall W.W., Gautier V.W. Nucleolar protein trafficking in response to HIV-1 Tat: rewiring the nucleolus. PLoS One 2012, 7(11):e48702.
30. Konig R., Zhou Y., Elleder D., Diamond T.L., Bonamy G.M., Irelan J.T., Chiang C.Y., Tu B.P., De Jesus P.D., Lilley C.E., Seidel S., Opaluch A.M., Caldwell J.S., Weitzman M.D., Kuhen K.L., Bandyopadhyay S., Ideker T., Orth A.P., Miraglia L.J., Bushman F.D., Young J.A., Chanda S.K. Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell 2008, 135(1):49-60.
31. Kraft-Terry S., Gerena Y., Wojna V., Plaud-Valentin M., Rodriguez Y., Ciborowski P., Mayo R., Skolasky R., Gendelman H.E., Melendez L.M. Proteomic analyses of monocytes obtained from Hispanic women with HIV-associated dementia show depressed antioxidants. Proteomics Clin. Appl. 2010, 4(8-9):706-714.
32. Larrieu D., Britton S., Demir M., Rodriguez R., Jackson S.P. Chemical inhibition of NAT10 corrects defects of laminopathic cells. Science 2014, 344(6183):527-532.
33. Lee Y.J., Wei H.M., Chen L.Y., Li C. Localization of SERBP1 in stress granules and nucleoli. FEBS J. 2014, 281(1):352-364.
34. Lemos T.A., Passos D.O., Nery F.C., Kobarg J. Characterization of a new family of proteins that interact with the C-terminal region of the chromatin-remodeling factor CHD-3. FEBS Lett. 2003, 533(1-3):14-20.
35. Li H., Wang B., Yang A., Lu R., Wang W., Zhou Y., Shi G., Kwon S.W., Zhao Y., Jin Y. Ly-1 antibody reactive clone is an important nucleolar protein for control of self-renewal and differentiation in embryonic stem cells. Stem Cells 2009, 27(6):1244-1254.
36. Lingappa J.R., Petrovski S., Kahle E., Fellay J., Shianna K., McElrath M.J., Thomas K.K., Baeten J.M., Celum C., Wald A., de Bruyn G., Mullins J.I., Nakku-Joloba E., Farquhar C., Essex M., Donnell D., Kiarie J., Haynes B., Goldstein D. Genomewide association study for determinants of HIV-1 acquisition and viral set point in HIV-1 serodiscordant couples with quantified virus exposure. PLoS One 2011, 6(12):e28632. for the Partners in Prevention, HSV/HIV T. S. T.
37. Liu H.T., Yung B.Y. In vivo interaction of nucleophosmin/B23 and protein C23 during cell cycle progression in HeLa cells. Cancer Lett. 1999, 144(1):45-54.
38. Liu L., Oliveira N.M., Cheney K.M., Pade C., Dreja H., Bergin A.M., Borgdorff V., Beach D.H., Bishop C.L., Dittmar M.T., McKnight A. A whole genome screen for HIV restriction factors. Retrovirology 2011, 8:94.
39. Luban J., Bossolt K.L., Franke E.K., Kalpana G.V., Goff S.P. Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B. Cell 1993, 73(6):1067-1078.
40. Lv J., Liu H., Wang Q., Tang Z., Hou L., Zhang B. Molecular cloning of a novel human gene encoding histone acetyltransferase-like protein involved in transcriptional activation of hTERT. Biochem. Biophys. Res. Commun. 2003, 311(2):506-513.
41. Molina L., Grimaldi M., Robert-Hebmann V., Espert L., Varbanov M., Devaux C., Granier C., Biard-Piechaczyk M. Proteomic analysis of the cellular responses induced in uninfected immune cells by cell-expressed X4 HIV-1 envelope. Proteomics 2007, 7(17):3116-3130.
42. Monette A., Pante N., Mouland A.J. HIV-1 remodels the nuclear pore complex. J. Cell Biol. 2011, 193(4):619-631.
43. Mukerji J., Olivieri K.C., Misra V., Agopian K.A., Gabuzda D. Proteomic analysis of HIV-1 Nef cellular binding partners reveals a role for exocyst complex proteins in mediating enhancement of intercellular nanotube formation. Retrovirology 2012, 9:33.
44. Naji S., Ambrus G., Cimermancic P., Reyes J.R., Johnson J.R., Filbrandt R., Huber M.D., Vesely P., Krogan N.J., Yates J.R., Saphire A.C., Gerace L. Host cell interactome of HIV-1 Rev includes RNA helicases involved in multiple facets of virus production. Mol. Cell. Proteomics 2012, 11(4). (M111 015313).
45. Nisole S., Krust B., Hovanessian A.G. Anchorage of HIV on permissive cells leads to coaggregation of viral particles with surface nucleolin at membrane raft microdomains. Exp. Cell Res. 2002, 276(2):155-173.
46. O'Doherty U., Swiggard W.J., Malim M.H. Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding. J. Virol. 2000, 74(21):10074-10080.
47. Obata Y., Yamamoto K., Miyazaki M., Shimotohno K., Kohno S., Matsuyama T. Role of cyclophilin B in activation of interferon regulatory factor-3. J. Biol. Chem. 2005, 280(18):18355-18360.
48. Ori A., Andres-Pons A., Beck M. The use of targeted proteomics to determine the stoichiometry of large macromolecular assemblies. Methods Cell Biol. 2014, 122:117-146.
49. Otake Y., Soundararajan S., Sengupta T.K., Kio E.A., Smith J.C., Pineda-Roman M., Stuart R.K., Spicer E.K., Fernandes D.J. Overexpression of nucleolin in chronic lymphocytic leukemia cells induces stabilization of bcl2 mRNA. Blood 2007, 109(7):3069-3075.
50. Penman S., Smith I., Holtzman E. Ribosomal RNA synthesis and processing in a particulate site in the HeLa cell nucleus. Science 1966, 154(3750):786-789.
51. Perry R.P. The cellular sites of synthesis of ribosomal and 4S RNA. Proc. Natl. Acad. Sci. USA 1962, 48(12):2179-2186.
52. Petrovski S., Fellay J., Shianna K.V., Carpenetti N., Kumwenda J., Kamanga G., Kamwendo D.D., Letvin N.L., McMichael A.J., Haynes B.F., Cohen M.S., Goldstein D.B. Common human genetic variants and HIV-1 susceptibility: a genome-wide survey in a homogeneous African population. AIDS 2011, 25(4):513-518.
53. +cells. Retrovirology 2010, 7:66.
54. Ringrose J.H., Jeeninga R.E., Berkhout B., Speijer D. Proteomic studies reveal coordinated changes in T-cell expression patterns upon infection with human immunodeficiency virus type 1. J. Virol. 2008, 82(9):4320-4330.
55. Roesch F., Meziane O., Kula A., Nisole S., Porrot F., Anderson I., Mammano F., Fassati A., Marcello A., Benkirane M., Schwartz O. Hyperthermia stimulates HIV-1 replication. PLoS Pathog. 2012, 8(7):e1002792.
56. Rycyzyn M.A., Reilly S.C., O'Malley K., Clevenger C.V. Role of cyclophilin B in prolactin signal transduction and nuclear retrotranslocation. Mol. Endocrinol. 2000, 14(8):1175-1186.
57. Salahuddin S.Z., Markham P.D., Wong-Staal F., Franchini G., Kalyanaraman V.S., Gallo R.C. Restricted expression of human T-cell leukemia-lymphoma virus (HTLV) in transformed human umbilical cord blood lymphocytes. Virology 1983, 129(1):51-64.
58. Santos S., Obukhov Y., Nekhai S., Bukrinsky M., Iordanskiy S. Virus-producing cells determine the host protein profiles of HIV-1 virion cores. Retrovirology 2012, 9(1):65.
59. Saphire A.C., Gallay P.A., Bark S.J. Proteomic analysis of human immunodeficiency virus using liquid chromatography/tandem mass spectrometry effectively distinguishes specific incorporated host proteins. J. Proteome Res. 2006, 5(3):530-538.
60. Schweitzer C.J., Jagadish T., Haverland N., Ciborowski P., Belshan M. Proteomic analysis of early HIV-1 nucleoprotein complexes. J. Proteome Res. 2013, 12(2):559-572.
61. Schweitzer C.J., Matthews J.M., Madson C.J., Donnellan M.R., Cerny R.L., Belshan M. Knockdown of the cellular protein LRPPRC attenuates HIV-1 infection. PLoS One 2012, 7(7):e40537.
62. Shen Q., Zheng X., McNutt M.A., Guang L., Sun Y., Wang J., Gong Y., Hou L., Zhang B. NAT10, a nucleolar protein, localizes to the midbody and regulates cytokinesis and acetylation of microtubules. Exp. Cell Res. 2009, 315(10):1653-1667.
63. Sheng W.Y., Wang T.C. Proteomic analysis of the differential protein expression reveals nuclear GAPDH in activated T lymphocytes. PLoS One 2009, 4(7):e6322.
64. Shevchenko A., Loboda A., Ens W., Schraven B., Standing K.G. Archived polyacrylamide gels as a resource for proteome characterization by mass spectrometry. Electrophoresis 2001, 22(6):1194-1203.
65. Smoot M.E., Ono K., Ruscheinski J., Wang P.L., Ideker T. Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics 2011, 27(3):431-432.
66. Stevenson S.E., Chu Y., Ozias-Akins P., Thelen J.J. Validation of gel-free, label-free quantitative proteomics approaches: applications for seed allergen profiling. J. Proteomics 2009, 72(3):555-566.
67. Su L., Hershberger R.J., Weissman I.L. LYAR, a novel nucleolar protein with zinc finger DNA-binding motifs, is involved in cell growth regulation. Genes Dev. 1993, 7(5):735-748.
68. Swartling F.J., Grimmer M.R., Hackett C.S., Northcott P.A., Fan Q.W., Goldenberg D.D., Lau J., Masic S., Nguyen K., Yakovenko S., Zhe X.N., Gilmer H.C., Collins R., Nagaoka M., Phillips J.J., Jenkins R.B., Tihan T., Vandenberg S.R., James C.D., Tanaka K., Taylor M.D., Weiss W.A., Chesler L. Pleiotropic role for MYCN in medulloblastoma. Genes Dev. 2010, 24(10):1059-1072.
69. Tu C., Li J., Sheng Q., Zhang M., Qu J. Systematic assessment of survey scan and MS2-based abundance strategies for label-free quantitative proteomics using high-resolution MS data. J. Proteome Res. 2014, 13(4):2069-2079.
70. Ueno T., Tokunaga K., Sawa H., Maeda M., Chiba J., Kojima A., Hasegawa H., Shoya Y., Sata T., Kurata T., Takahashi H. Nucleolin and the packaging signal, psi, promote the budding of human immunodeficiency virus type-1 (HIV-1). Microbiol. Immunol. 2004, 48(2):111-118.
71. Warren K., Wei T., Li D., Qin F., Warrilow D., Lin M.-H., Sivakumaran H., Apolloni A., Abbott C.M., Jones A., Anderson J.L., Harrich D. Eukaryotic elongation factor 1 complex subunits are critical HIV-1 reverse transcription cofactors. Proc. Natl. Acad. Sci. USA 2012, 109(24):9587-9592.
72. Weiss A., Wiskocil R.L., Stobo J.D. The role of T3 surface molecules in the activation of human T cells: a two-stimulus requirement for IL 2 production reflects events occurring at a pre-translational level. J. Immunol. 1984, 133(1):123-128.
73. Wu-Baer F., Lane W.S., Gaynor R.B. Identification of a Group of Cellular Cofactors That Stimulate the Binding of RNA Polymerase II and TRP-185 to Human Immunodeficiency Virus 1 TAR RNA. J. Biol. Chem. 1996, 271(8):4201-4208.
74. Yurchenko V., O'Connor M., Dai W.W., Guo H., Toole B., Sherry B., Bukrinsky M. CD147 is a signaling receptor for cyclophilin B. Biochem. Biophys. Res. Commun. 2001, 288(4):786-788.
75. Zhou H., Xu M., Huang Q., Gates A.T., Zhang X.D., Castle J.C., Stec E., Ferrer M., Strulovici B., Hazuda D.J., Espeseth A.S. Genome-scale RNAi screen for host factors required for HIV replication. Cell Host Microbe 2008, 4(5):495-504.